Neuroendocrine carcinomas of diverse sites

Pathology Case Reviews

Volumn 11, Issue 6, 2006, Pages 282-291

  Osamura, Robert Y ^a   Inomoto, Chie ^a   Kajiwara, Hiroshi ^a   DeLellis, Ronald A ^b  

^a TOKAI UNIVERSITY   (Japan)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Chromogranins; Hormones; Neuroendocrine carcinomas; Neuroendocrine markers; Neuroendocrine tumors

Indexed keywords

CORTICOTROPIN;

CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; ECTOPIC CORTICOTROPIN PRODUCTION; ESOPHAGUS CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; SMALL CELL CARCINOMA; THYMOMA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; UTERINE CERVIX CARCINOMA;

EID: 33845419427     PISSN: 10829784     EISSN: 15334015     Source Type: Journal    
DOI: 10.1097/01.pcr.0000251136.88078.43     Document Type: Review

References (71)

1. DeLellis RA, Osamura RY. Neuroendocrine tumors: an overview. Pathol Case Rev. In press.
2. nd ed. Berlin, Germany: Springer-Verlag; 2000.
3. Heitz PU, Komminoth P, Perren A. Pancreatic endocrine tumours. In: DeLellis RA, Lloyd RV, Heitz PU, et al, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press; 2004:177-182.
4. Begin LR. Renal carcinoid tumor. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:81.
5. Guillou L. Neuroendocrine carcinoma of the kidney. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:82.
6. Rothwell DL, Vorstman B, Patton I, et al. Intrarenal pheochromocytoma. Urology. 1983;21:175-177.
7. Parham DM, Roloson GJ, Feely M, et al. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol. 201;25:133-146.
8. Capella C, Eusebi V, Rosai J. Primary oat cell carcinoma of the kidney. Am J Surg Pathol. 1984;8:855-861.
9. Essenfeld H, Manivel JC, Benedetto P, et al. Small cell carcinoma of the renal pelvis: a clinico-pathological, morphological and immunohistochemical study of 2 cases. J Urol. 1990;144:344-347.
10. Begin LR, Guy L, Jacobson SA, et al. Renal carcinoid and horseshoe kidney: a frequent association of two rare entities: a case report and review of the literature. J Surg Oncol. 1998;68:113-119.
11. Resnick ME, Uterberger H, McLoughlin PT. Renal carcinoid producing the carcinoid syndrome. Med Times. 1966;94:895-896.
12. Gleason MH, Bloom SR, Polak JM, et al. Endocrine tumor of the kidney affecting small bowel structure, motility and absorptive functions. Gut. 1971;12:773-782.
13. McVey RJ, Banerjee SS, Eyden BP, et al. Carcinoid tumor originating in a horseshoe kidney. In Vivo. 2002;16:197-199.
14. Kurzer E, Leveillee RJ, Morillo G. Rare case of carcinoid tumor arising within teratoma in kidney. Urology.2005;66:658.
15. Isobe H, Takashima H, Higashi N, et al. Primary carcinoid tumor in a horseshoe kidney. Int J Urol. 2000;7:184-18.
16. Rodriguez-Covarrubias F, Gomez X, Valerio JC, et al. Carcinoid tumor arising in a horseshoe kidney. Int Urol Nephrol.2006;(Epub ahead of print).
17. Takeshima Y, Inai K, Yoneda K. Primary carcinoid tumor of the kidney with special reference to its histogenesis. Pathol Int. 1996;46:894-900.
18. Erickson LA, Papouchado B, Dimashkieh H, et al. CdX2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol. 2004;15:247-252.
19. Marx A, Shimosato V, Kuo TT, et al. Thymic neuroendocrine tumors. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2006:188:-195.
20. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus: a clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000;114:100-110.
21. Moran C. Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification. Semin Diagn Pathol. 2005;22:223-229.
22. Teh BT, Zedenius J, Kytola S, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228:99-105.
23. Gibril F, Chen YJ, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1003;88:1066-1081.
24. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from the literature: a comparative study between typical carcinoids and atypical varieties. Am Thorac Cardiovas Surg. 1999;5:285-292.
25. Suster S, Moran CA. Neuroendocrine neoplasms of the mediastinum. Am J Clin Pathol. 2001;115(suppl):S17-S27.
26. Wick MR, Scheithauer BW. Thymic carcinoid: a histologic, immunohistochemical and ultrastructural study of 12 cases. Cancer. 1984;53:475-484.
27. Wick MR, Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol. 1991;8:35-51.
28. Hishima T, Fukayama M, Hayaski Y, et al. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hum Pathol. 1998;29:330-338.
29. Kuo TT. Carcinoid tumor of the thymus with divergent sarcomatoid differentiation: report of a case with histogenetic consideration. Hum Pathol. 1994;25:319-323.
30. Oliveira AM, Tazelear HD, Myers JL, et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well differentiated neuroendocrine tumors of other sites. Am J Surg Pathol. 2001;25:815-819.
31. di Sant'Agnese PA, Egevad L, Epstein, JI, et al. Neuroendocrine tumours. In: Bble JE, Sauter G, Epstein JI, et al. Tumors and the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:207-208.
32. Haukaas SA, Halvorse OJ, Nygaard SJ, et al. Cushing's syndrome in prostate cancer: an aggressive course of prostatic malignancy. Urol Int. 1999;63:126-129.
33. diSant'Agnese PA. Neuroendocrine cells of the prostate and neuroendocrine differentiation: a review of morphological aspects. Urology. 1998;51(5A suppl):121-124.
34. Abrahamsson PA, Dizeyi N, Alm P, et al. Calcitonin and calcitonin gene related peptide in the human prostate gland. Prostate. 2000;44:181-186.
35. Jiborn T, Bjartell A, Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment. Urology. 1998;51:585-589.
36. Hirano D, et al. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol. 2004;45:586-592.
37. Mosca A, Bernuti A, Russo L, et al. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. J Endocrinol Invest. 2005;28(11 suppl):141-145.
38. Reyes A, Moran CA. Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med. 2004;128:166-168.
39. Ghannoum JE, DeLellis RA, Shin SJ. Primary carcinoid of the prostate with concurrent adenocarcinoma: a case report. Int J Surg Pathol. 2004;12:167-170.
40. Zarkovic A, Masters J, Carpenter L. Primary carcinoid tumour of the prostate. Pathology. 2005;37:184-186.
41. Ro JY, Tetu B, Ayala AG, et al. Small cell carcinoma of the prostate, II: immunohistochemical and electron microscopic studies of 18 cases. Cancer. 1987;59:977-982.
42. Clegg N, Ferguson C, True LD, et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate. 2003;55:54-64.
43. Kawai S, Hiroshima K, Tsukamoto Y, et al. Small cell carcinoma of the prostate expressing prostate specific antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: an autopsy case report. Pathol Int. 2003;53:892-896.
44. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinoma from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217-1223.
45. Helpap B, Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch. 1999;434:385-391.
46. Petraki C, Vaclamatzia M, Petraki K, et al. Prostate cancer with small cell morphology: an immunophenotypic subdivision. Scand J Urol. 2005;39:455-463.
47. Evans AJ, Humphrey PA, Belani J, et al. Large cell neuroendocrine carcinoma of the prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol. 2006;30:684-693.
48. Brenner B, Tang LH, Klimstra DS, et al. Small cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730-2739.
49. Brenner B, Shah MA, Gonen M, et al. Small cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer. 2004;90:1720-1726.
50. Capella C, Solcia E, Sobin LH. Endocrine tumors of the esophagus. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000:26-27.
51. Noguchi T, Takeno S, Kato T, et al. Small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of six cases. Dis Esophagus. 2003;16:252-258.
52. Iwamura T, Shibata N, Termuhlen P, et al. Superficial neuroendocrine carcinoma of the esophagus. Digest Endosc. 2001;13:216-219.
53. Wu Z, Ma JY, Yang JJ, et al. Primary small cell carcinoma of esophagus: report of 9 cases and review of literature. World J Gastroenterol. 2004;10:3680-3682.
54. Wilson CI, Summerall J, Willis I, et al. Esophageal collision tumor (large cell neuroendocrine carcinoma and papillary carcinoma) arising in a Barrett esophagus. Arch Pathol Lab Med. 2000;124:411-415.
55. Albores-Saavedra J, Gersell D, Gilks CB, et al. Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med. 1997;121:34-39.
56. Gersell DJ, Mazoujian G, Mutch DR, et al. Small cell undifferentiated carcinoma of the cervix: a clinico-pathologic, ultrastructural and immunocytochemical study of 15 cases. Am J Surg Pathol. 1988;12:684-698.
57. Ishida GM, Kato N, Hayasaka T, et al. Small-cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol. 2004;23:366-372.
58. Wang KL, Yang YC, Wang TY, et al. Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother. 2006;18:209-216.
59. Hashi A, Yasumizu T, Yoda I, et al. A case of small cell carcinoma of the uterine cervix presenting Cushing's syndrome. Gynecol Oncol. 1996;61:427-431.
60. Albores-Saavedra J, Latif S, Carrick KS, et al. CD56 reactivity in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol. 2005;24:113-117.
61. Stoler MH, Mills SE, Gersell DJ, et al. Small cell neuroendocrine carcinoma of the cervix: a human papilloma virus 18 associated cancer. Am J Surg Pathol. 1991;15:28-32.
62. Matsumoto N, Fuji T, Ishikawa M, et al. p16 Overexpression and human papilloma virus infection in small cell carcinoma of the uterine cervix. Hum Pathol. 2003;34:778-783.
63. Grayson W, Rheumtula HA, Taylor LF, et al. Detection of human papilloma virus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases. J Clin Pathol. 2002;55:108-114.
64. Toker C. Trabecular carcinoma of the skin. Arch Dematol. 1972;105:107-110.
65. Tang C-K, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42:2311-2321.
66. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1-4.
67. Sibley RK, Dahl D. Primary neuroendocrine (Merkel cell?) carcinoma of the skin, II: an immunocytochemical study of 21 cases. Am J Surg Pathol. 1985;9:109-116.
68. Brinkschmidt C, Stolze C, Fahrenkamp AG, et al. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in Merkel cell carcinoma of the skin: an immunohistochemical study of 18 cases suggesting two types of Merkel cell carcinoma. Appl Immunohistochem. 1995;3:37-44.
69. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor-1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol. 2000;31:58-62.
70. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-2309.
71. Koljonen V, Haglund C, Tukianinen E, et al. Neuroendocrine differentiation in primary Merkel cell carcinoma: possible prognostic significance. Anticancer Res. 2005;25:853-858.